About
Ronald N. Marcus, MD, affiliated with Bristol Myers Squibb in Princeton, New Jersey, has published extensively on the treatment of schizophrenia, schizoaffective disorders, major depressive disorder, bipolar disorder, and child and adolescent psychiatry. His work includes clinical trials and safety evaluations of antipsychotic medications such as aripiprazole and xanomeline, focusing on agitation, irritability, and metabolic effects in diverse patient populations. Marcus's research spans from 2006 to 2025 and frequently involves co-authors Robert D. McQuade, William H. Carson, Berit X. Carlson, Raymond Sanchez, and Robert M. Berman.
